The latest in the deals space in India has seen PE firm Gaja Capital which recently closed its third fund, being in final talks to invest $20 million in Kangaroo Kids Education Ltd, while pharmaceutical firm Jubilant Life Sciences has received board approval to acquire a pharma company in the US.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
